• Doxycycline: Protocols and Innovations in Cancer Research

  2026-07-27

  Doxycycline is more than a tetracycline antibiotic; its potent metalloproteinase inhibition and antiproliferative effects offer unique advantages for cancer and tissue engineering workflows. This article decodes advanced experimental setups, troubleshooting, and new mechanotransduction insights, guiding researchers from setup to successful application.

• Salvianolic Acid B for Pulmonary Fibrosis: Applied Protocols

  2026-07-27

  Salvianolic acid B (Dan Shen Suan B) is transforming pulmonary fibrosis research by directly targeting LH2-mediated collagen cross-linking, offering a precision tool for dissecting extracellular matrix remodeling. This article decodes experimental workflows, troubleshooting tactics, and actionable tips for maximizing the compound’s antifibrotic value in preclinical models.

• Verbascoside: Precision PKC/NF-κB Inhibition in Translationa

  2026-07-26

  Explore how Verbascoside, a next-generation PKC/NF-κB inhibitor, empowers translational researchers to dissect complex cell signaling underlying osteoclastogenesis, inflammation, and pain sensitization. This thought-leadership article synthesizes mechanistic insight, comparative positioning, and protocol strategies, with evidence from both molecular neurobiology and practical assay design. The discussion is anchored in current research on TMJ inflammation, highlighting how Verbascoside bridges mechanistic discovery with actionable pathways for therapeutic innovation.

• SFRP1 Attenuates Oral Submucous Fibrosis via Wnt/β-Catenin I

  2026-07-25

  The referenced study reveals that SFRP1 overexpression reduces neutrophil infiltration and suppresses the Wnt/β-catenin pathway, thereby alleviating oral submucous fibrosis (OSF) in an arecoline-induced mouse model. These mechanistic insights highlight the dual anti-fibrotic and immunomodulatory potential of SFRP1, positioning Wnt pathway modulation as a promising avenue for OSF research.

• Ferroptosis-Gene Signature Predicts HCC Prognosis, Atorvasta

  2026-07-24

  This study establishes a novel prognostic model based on ferroptosis-related genes in hepatocellular carcinoma (HCC) and experimentally demonstrates that atorvastatin can induce ferroptosis and suppress HCC cell growth and migration. The findings highlight a promising biomarker-driven approach for risk stratification and support the repurposing of HMG-CoA reductase inhibitors in liver cancer research.

• BV6: Selective IAP Antagonist for Apoptosis Induction in Can

  2026-07-24

  BV6 is a selective IAP antagonist that induces apoptosis in cancer cells and enhances radiosensitivity, with a documented IC50 of 7.2 μM in NSCLC models. Its use is supported by peer-reviewed evidence and standardized protocols, making it a credible tool in translational oncology and endometriosis research.

• Nano-Granulated Zoledronate Redirects Immunometabolism for E

  2026-07-23

  The study by Chen et al. introduces a nano-granulated form of zoledronate (Nano-ZD) that targets the mevalonate pathway in innate immune cells, enhancing both vaccine-induced and antitumor immunity. By leveraging nanotechnology for lymph node-specific delivery, the research demonstrates a promising strategy for metabolic adjuvant design and immune modulation.

• EZ Cap™ Firefly Luciferase mRNA: Enhanced Reporter for mRNA

  2026-07-23

  EZ Cap™ Firefly Luciferase mRNA is a high-performance, Cap 1-structured mRNA reporter optimized for robust translation and stability. Incorporating an engineered poly(A) tail and 5' cap, it sets a benchmark for mRNA delivery and in vivo bioluminescent assays. This product enables reproducible gene regulation studies and precise molecular imaging.

• Lyotropic Phase Behavior of Coil-Bottlebrush Diblocks in Ion

  2026-07-22

  This study systematically explores how coil-bottlebrush diblock copolymers self-assemble in a range of alkylimidazolium-based ionic liquids, revealing that three-dimensional network morphologies form robustly regardless of ionic liquid chain length. These findings challenge prior assumptions about the necessity of precise solvent control, offering new flexibility for nanostructured material design.

• Salvianolic acid B: Applied Protocols for Pulmonary Fibrosis

  2026-07-22

  Salvianolic acid B (Dan Shen Suan B) uniquely targets lysyl hydroxylase 2, enabling precise control of collagen cross-linking in advanced pulmonary fibrosis research. This article delivers actionable workflows and troubleshooting tactics, leveraging APExBIO’s high-purity compound for reproducible, mechanism-driven antifibrotic studies.

• Necrosulfonamide: Specific MLKL Inhibition in Necroptosis As

  2026-07-21

  Necrosulfonamide (NSA) is a highly selective MLKL inhibitor used to dissect necroptotic cell death pathways. NSA blocks membrane disruption in necroptosis, without interfering with MLKL phosphorylation or apoptosis in non-necroptotic contexts. Its nanomolar potency and specificity make it a benchmark reagent for necroptosis assays in cancer and cardiovascular research.

• HBTU: Precision Peptide Bond Formation for Complex Synthesis

  2026-07-21

  HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) sets the benchmark for racemization-resistant peptide synthesis. Explore advanced workflows, troubleshooting, and real-world applications that leverage HBTU's unique solubility and stability for efficient, high-fidelity peptide assembly.

• Rhodamine 123 (chloride): Advanced P-Glycoprotein Assay Desi

  2026-07-20

  Rhodamine 123 (chloride) sets the benchmark for real-time, high-sensitivity membrane transport assays, offering robust quantification of P-glycoprotein and OATP1A2 activity. Discover protocol innovations, troubleshooting insights, and translational workflow enhancements that distinguish this dye—especially for multidrug resistance and transporter research.

• Applied Cell Viability: Live-Dead Cell Staining Kit I Workfl

  2026-07-20

  The Live-Dead Cell Staining Kit I (Calcein AM/PI) from APExBIO empowers precise fluorescence-based viability and cytotoxicity assays in mammalian cells. This article details step-by-step protocols, advanced workflow integration, and troubleshooting strategies, translating the latest biomaterial research into actionable assay design for cell health and regeneration studies.

• Discovery and Characterization of Forsythoside E in Forsythi

  2026-07-19

  The reference paper reports the isolation and structural elucidation of Forsythoside E, a known phenylethanoid glycoside, from Forsythia suspensa fruits alongside several new congeners. This foundational phytochemical work underpins subsequent immunometabolic research and therapeutic exploration involving Forsythoside E as a selective PKM2 inhibitor and macrophage modulator.

16292 records 1/1087 page Next 12345 下5页 Last page